InvestorsHub Logo

HyGro

02/24/22 4:46 PM

#204494 RE: Pinseekr #204493

FDA and company agreed on the dosing. That what was in the trial protocol and that's all that counts.

The FDA Statement was because NP misrepresented and manipulated the clinical trial data -- that's illegal and now the SEC and the DOJ investigation. Likely going to end up with NP doing a perp walk.

You can try to rationalize it all you want, but the company agreed to the protocol. They didn't have to, they were running eIND using a 4 dose protocol and the FDA had accepted it. But the FDA guidelines is what count for statistics, and NP violated it repeatedly. Each trial is an independent event.

Committing fraud and being called out is certainly NOT a "hit piece." It is publicly notifying HCPs and investors as required by law. Shareholders don't like it because it cost them money. They can make up any excuse they want, but it was a failed trial and fraud to spin something positive out of it. Just watch what is going to happen when the SEC and DOJ comes down on CYDY with both feet. Shareholders are not going to be happy.

PNW_Ironman

02/27/22 4:55 PM

#204740 RE: Pinseekr #204493

Wonder what it would take to stop this pattern once and for all?